Reliant Medical Group   Report issue

Academic/Hospital Phase 2
Founded: Worcester MA United States (1929)
Status: Acquired by Optum (2018)

Organization Overview

First Clinical Trial
2001
NCT00053001
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2001

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Fallon Clinic

Active Ingredients

Drugs in Phase 2 Trials (2)

epoetin (Epogen) (1 trial)

thalidomide (Thalomid) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia (Phase 2)

Myelodysplastic-Myeloproliferative Diseases (Phase 2)

Myelodysplastic Syndromes (Phase 2)

Myeloproliferative Disorders (Phase 2)

Preleukemia (Phase 2)

Syndrome (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 2